AU Medical Center uses biosensors to predict changes in med-surge patients

AU Medical Center is the first hospital in the country to use the Philips biosensor in the clinical environment. The hospital decided to test the device on its medical-surgical population to help nurses who sometimes care for up to six med-surge patients at a time, all with varying health concerns, said Kevin Dellsperger, M.D., vice president and chief medical officer at AUMC in an interview with FierceHealthcare.

For a nurse taking care of six patients, it may be several hours between patient assessments. During that time, a patient could be exhibiting subtle signs of deterioration.

“Other than a patient self-actuating a call line or a family member calling for help, there is no way that nurse could know what is going on,” Dellsperger said.

The biosensor device, manufactured by Netherlands-based tech company Philips, pairs with the IntelliVue Guardian Solution, software that integrates clinical decision support analytics with patient information to provide early warning signs for intervention.

FierceHealthcare: AU Medical Center uses biosensors to predict changes in med-surge patients

Feb. 24, 2017